BILIVERDIN DIHYDROCHLORIDE
- CAS No.
- 55482-27-4
- Chemical Name:
- BILIVERDIN DIHYDROCHLORIDE
- Synonyms
- BiliverdinHCl;BILIVERDIN HYDROCHLORIDE;BILIVERDIN DIHYDROCHLORIDE;NMGSCKVUURHINJ-DAZZNVSASA-N;Biliverdin hydrochloride (Microbial source);3-[(2Z)-2-[[3-(2-carboxyethyl)-5-[(E)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid;3-[(2Z,5E)-2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoicacid,dihydrochloride
- CBNumber:
- CB2226954
- Molecular Formula:
- C33H35ClN4O6
- Molecular Weight:
- 619.12
- MOL File:
- 55482-27-4.mol
- MSDS File:
- SDS
- Modify Date:
- 2023/4/23 13:52:06
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| WGK Germany | 3 |
BILIVERDIN DIHYDROCHLORIDE price More Price(5)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | 30891 | Biliverdin hydrochloride ≥97.0% (TLC) | 10MG | ₹4416.6 | 2022-06-14 | Buy | |
| Sigma-Aldrich(India) | 30891 | Biliverdin hydrochloride ≥97.0% (TLC) | 55482-27-4 | 10MG | ₹4416.6 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | 30891 | Biliverdin hydrochloride ≥97.0% (TLC) | 55482-27-4 | 50MG | ₹10651.8 | 2022-06-14 | Buy |
| ALFA India | ALF-J65226-MD | Biliverdin hydrochloride | 55482-27-4 | 250mg | ₹48401 | 2022-05-26 | Buy |
| ALFA India | ALF-J65226-MC | Biliverdin hydrochloride | 55482-27-4 | 100mg | ₹25392 | 2022-05-26 | Buy |
BILIVERDIN DIHYDROCHLORIDE Chemical Properties,Uses,Production
Uses
Biliverdin dihydrochloride was found responsible for cytoprotection. It was also found to induce tolerance to cardiac allografts. Biliverdin hydrochloride may regulate the cellular heme degradation process by occupying the heme binding site on heme oxygenase which would prevent access of the substrate to the catalytic site of the enzyme.
General Description
Biliverdin?(BV) is considered as a near-infrared (NIR)-absorbing pigment, that is endogenic. It is a linear tetrapyrrolic intermediate of heme degradation (heme catabolism) to bilirubin. The bile of amphibia and birds contains only biliverdine, no bilirubin.
Biochem/physiol Actions
Biliverdin (BV) is an excellent anti-inflammatory agent that protects against lipopolysaccharides (LPS)-induced lung injury in mouse endothelial cells. It aids protection in polymicrobial sepsis. Biliverdin has cytoprotective effects on rat livers and protects from prolonged ischemia and reperfusion injury. It also shows antioxidant activities.
BILIVERDIN DIHYDROCHLORIDE Preparation Products And Raw materials
BILIVERDIN DIHYDROCHLORIDE Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
| Alfa Aesar | 1 800 209 7001 | Maharashtra, India | 6913 | 58 | Inquiry |
| Chengdu Aslee Biopharmaceuticals, Inc. | 28-85305008 | CHINA | 964 | 58 | Inquiry |
| Finetech Industry Limited | +86-27-87465837 +8618971612321 | China | 9626 | 58 | Inquiry |
| Hubei DAHAO Chemical Co., Ltd. | 027-59106191 13986034860 | China | 9913 | 58 | Inquiry |
| Hubei Qifei Pharmaceutical Chemical Co., Ltd | 027-59322506 18071128681 | China | 9978 | 58 | Inquiry |
| Shanghai Aladdin Bio-Chem Technology Co.,LTD | 400-400-6206333 18521732826 | China | 25014 | 65 | Inquiry |
| Baoji Didu Pharmaceutical and Chemical Co., Ltd | 029-61856358 15829046862 | China | 10011 | 58 | Inquiry |
| Shanghai Haohong Scientific Co., Ltd. | 400-400-8210725 | China | 40041 | 58 | Inquiry |
| Hubei wei shi reagent group ltd., company | 186-27096350 18627096350 | China | 2663 | 58 | Inquiry |